Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Baxter imports IV fluids
Baxter imports IV fluids as Hurricane Helene triggers U.S. shortage
Baxter International began shipments of intravenous products to the United States from two international facilities last week, it said on Monday, as it works to bring a hurricane-hit plant in North Carolina back online amid a shortage of the essential medical product.
Baxter bolsters IV supplies with imports to address US shortages in wake of Hurricane Helene
Baxter International, which was forced by flooding from Hurricane Helene to temporarily halt production at its North Carolina facility, has started
Chicago hospitals feel relief as Baxter responds to IV fluid shortage
Hospitals, especially in Chicago, have been grappling with dwindling supplies of IV solutions and dialysis products since the plant closure last month.
Baxter starts importing IV fluid to stem shortage
As the manufacturer works to maximize shipments of medical supplies out of its facility knocked out by Hurricane Helene, hospitals feeling the supply crunch got the all-clear to make their own fluid.
Baxter importing IV fluids to help alleviate shortage
Baxter International began shipments of intravenous products to the United States from two international facilities last week, it said on Monday, as it works to bring a hurricane-hit plant in
Baxter to import IV fluids to relieve US shortages
Baxter International will import IV fluids from two of its international manufacturing facilities to address supply shortages in the U.S. The company is also ramping up production and utilizing air and other transportation methods to expedite delivery, according to an Oct. 14 update from the company.
Baxter imports IV fluids as hurricane hits supply from US plant
Baxter International began shipments of intravenous products to the United States from two international facilities last week, it said on Monday, as it works to bring a hurricane-hit plant in North Carolina back online.
1d
Baxter Is A Strong Buy: The Turnaround Story You Can't Ignore
Baxter's acquisition of Hill-Rom and subsequent challenges have been addressed, setting the stage for recovery. Click here to ...
WAGMTV
21h
Hospitals ration supplies, postpone surgeries after Helene damages IV fluid manufacturing site
The impacted facility is Baxter International’s North Cove site located just east of hard-hit Asheville, North Carolina. It ...
bovnews
17h
What’s Fueling Baxter International Inc (BAX) Stock’s -3.82% Loss Below Its 200-Day SMA?
On Friday, Baxter International Inc (BAX) stock saw a decline, ending the day at $36.54 which represents a decrease of $-0.49 or -1.32% from the prior close of $37.03. The stock opened at $37.14 and ...
Yale Daily News
10h
Hurricane Helene halts IV supply chain, Connecticut hospitals brace for impact
Hospitals across Connecticut are taking measures to conserve IV fluid supplies after Hurricane Helene damaged an IV ...
4d
on MSN
How Hurricane Helene Damage to a Baxter Plant Is Causing a Hospital Supply Chain Crisis
It’s yet another sign of how consolidation in the medical supply chain has created enormous risks for the entire health ...
Fierce Healthcare
5d
Baxter International increases IV fluid allocations to hospitals with plans to resume full inventory by year-end
The American Hospital Association wants the Biden administration to take immediate actions to increase the supply of IV ...
1d
on MSN
Western North Carolina IV plant still shut down. Supply shortage 'affecting hospitals across the United States'
The Baxter International plant in Marion, North Carolina supplies a majority of US hospitals with IV bags. However, with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
North Carolina
Hurricane Helene
IV fluids
United States
Food and Drug Administration
Feedback